1. Home
  2. BNTC vs RMR Comparison

BNTC vs RMR Comparison

Compare BNTC & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • RMR
  • Stock Information
  • Founded
  • BNTC 1995
  • RMR 1986
  • Country
  • BNTC United States
  • RMR United States
  • Employees
  • BNTC N/A
  • RMR N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • RMR Professional Services
  • Sector
  • BNTC Health Care
  • RMR Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • RMR Nasdaq
  • Market Cap
  • BNTC 339.8M
  • RMR 306.9M
  • IPO Year
  • BNTC N/A
  • RMR N/A
  • Fundamental
  • Price
  • BNTC $16.11
  • RMR $16.89
  • Analyst Decision
  • BNTC Strong Buy
  • RMR Buy
  • Analyst Count
  • BNTC 7
  • RMR 2
  • Target Price
  • BNTC $24.43
  • RMR $32.00
  • AVG Volume (30 Days)
  • BNTC 37.6K
  • RMR 175.9K
  • Earning Date
  • BNTC 05-12-2025
  • RMR 05-06-2025
  • Dividend Yield
  • BNTC N/A
  • RMR 10.44%
  • EPS Growth
  • BNTC N/A
  • RMR N/A
  • EPS
  • BNTC N/A
  • RMR 0.97
  • Revenue
  • BNTC N/A
  • RMR $199,940,000.00
  • Revenue This Year
  • BNTC N/A
  • RMR $371.91
  • Revenue Next Year
  • BNTC N/A
  • RMR $1.02
  • P/E Ratio
  • BNTC N/A
  • RMR $17.70
  • Revenue Growth
  • BNTC N/A
  • RMR N/A
  • 52 Week Low
  • BNTC $4.75
  • RMR $16.89
  • 52 Week High
  • BNTC $15.97
  • RMR $26.43
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 70.37
  • RMR 31.88
  • Support Level
  • BNTC $14.90
  • RMR $17.03
  • Resistance Level
  • BNTC $15.97
  • RMR $17.49
  • Average True Range (ATR)
  • BNTC 1.03
  • RMR 0.46
  • MACD
  • BNTC 0.32
  • RMR -0.07
  • Stochastic Oscillator
  • BNTC 85.59
  • RMR 5.66

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: